T HE APPEARANCE of a new, effective antihypertensive drug no longer surprises physicians. They are now accustolued to treating hypertension, more or less effee-tive&y, because between 1950 and 1958, 4 types of antihypertensive drugs became available for clinical use. These drugs are by no means ideal, but they have been lifesaving in some patients with malignant hypertension or cardiac failure, and they have become progressively freer of side effects. Accordingly, physicians expect to see developed an antihypertensive drug that is effective in most patients, easy to administer, and without important side effects. These expectations will probably be fulfilled, but until then such optimism should not be allowed to dull critical analysis of new drugs as they become available.
Over a year ago bretylium and guanethidine were released for clinical trial as antihypertensive drugs with novel mechanisms of action.1 2 Both interfere with sympathetic nerve function, either by depressing norepinephrine release or by depleting blood vessels and heart of this amine. Their antihypertensive effects are thought due to these actions. The advantage of these 2 drugs is that they suppress sympathetic function without causing parasympathetic blockade.
Drugs with such selective effects on the nervous system could have clear therapeutic From the Research Division of the Cleveland Clinic and the Frank E. Bunts Educational Institute, Cleveland, Ohio.
Circulation, Volume, XXII, August 1960 advantage. A brief look at the other 4 widely used agents reveals that, for the most part, they act through nervous mechanisms. In the case of the ganglion-blocking drugs, sympathetic vasomotor outflow is blocked at the ganglia; reserpine not only diminishes outflow from the central nervous system, but also depletes heart and blood vessels of norepinephrine; oral diuretics, at least in the early days of treatment, act predominantly through sympathetic pathways. Hydralazine, alone, does not seem to have a major nervous system action. We know that the sympathetic nervous system is concerned in the maintenance of arterial pressure. Whether this is greater than normal in most patients with hypertension is not known. Whatever the circumstance may be, ganglion-blocking agents lower blood pressure. Because they cause parasympathetic as well as sympathetic blockade, they can interfere seriously with function of the gastrointestinal and genitourinary tracts. This is their main disadvantage. Since both bretylium and guanethidine have the property of depressing only sympathetic function, they might well represent an advance in the therapy of hypertension.
Before any drug can be accepted as effectively antihypertensive, however, it must be shown to cause neither tolerance nor early or late incapacitating side effects. Further it must be determined whether the level of arterial pressure can be reduced sufficiently in order that the drug be classed as effectively antihypertensive. On this there apparently is no agreement. Some investigators emphasize orthostatie hypotension as the criterion for a good response; others, a reduetion in mean arterial blood pressure of 20 mm. Hg or more. We insist that an effeetive drug lower pressure in both the supine anid standinlg positions. This last opinion is based on experienee with long-term treatment of malignaint hypertension, which showed that those patients who achieved good control of supine arterial pressure lived longer than did those whose pressure was lowered only in the standing position.3
Both bretylium and guanethidine have been under elinical study for over a year alnd suffieient evidenee has accumulated to show that bretylium has serious disadvantages and that guanethidine, although not ideal, is a potent drug of long-term effectiveness. Sinee both depress sympathetic function, both cause orthostatic hypotension, and this can occur without reduction in supine arterial pressure. This propensity indicates that neither drug ean be used as casually as are reserpine and oral diuretics, and also that there may be some disagreement as to their effectiveness as antihypertensive agen-ts. The first report on the use of bretylium emphasized orthostatic hypotensioni, indicating this as a measure of effectiveness.-Subsequent reports have been less enthusiastic. 4 We have found that it causes primarily orthostatic hypotension and that wheni deereases in supilne pressure are aehieved, they, are not usually maintaimed for more than a few weeks.6 This indicates development of toleranee and is in accord with the experienee of others. 4 5 As yet no reports of toleranee to guanethidine have appeared nor has this been our experience in 16 months of use.- 9 We finid guanethidine to achieve sustained decreases of arterial pressure ill both supinie and standing positions.
Bretylium eaused parotid pain in 10 of 13 patienits whom we treated.6 It appeared witlh the first few bites of food and usually disappeared if the patient eould conitiniue to eat: however, in a few the pain was so severe that they did not eat enough to mainitaini body weight. Its cause is obseure; it is not due to obstructioni of Stenson "s ducts, and salivary production in response to citric acid has beeni found to be normal. The dose of bretylium given may inifluence the rapidity with which the paini develops after treatment is begun; we used 2 to 8 Gm. per day and observed onset of paini in the early weeks or milonths of treatment; others using smaller doses have not emphasized this side effect. 4 5 Eveni after the drug has been discontinued for matly weeks, the pain may persist. In this regard, it is interesting that this syinptom has beeni reported in 1 patielnt with spontaneous orthostatic hypotension.10 Guanethidilne's most frequent side effeet is mild diarrhea. It usually responds to parasympathetic-blocking drugs and often lessen-s as treatimenit is conitinued. Occasionally reduction in drug dosage is necessary. It may lresult from autonomic imnbalanee of the intestinal tract, silnce suppression of sympathetic funLetioln would leave parasympathetic funetion uncheeked.
Both bretyliuin and guanethidine represent a more specific therapeutic attack on that conmponent of hypertension maintained by sympathetic vasomnotor tone. After 16 months of study with guanethidine it is our opinioni that it is a reasonablv effective antihypertensive agent with mninimal side effects. Bretylium has the disadvantage of more readily developing tolerance and in large doses, eliciting parotid pain of muoderatelv severe grade. IRVINE H. PAGE TIARRIET P. DUSTAN 2 I am the last to deny medical science credit for remarkable achievement in the conquest of disease and for disinterested devotion to human betterment. Actually, I think that medicine is doing its job admirably if that job is conceived to be only the care of the human organism, taken "as is," and the remission of venial biological sins which are consequent upon civilized man's abuse of his bodily inheritance. I appeal to medicine because it is the one branch of applied science which might be expected to realize not only that human behavior is a function of the human organism, but that all animal organisms exist and transmit their qualities through the mechanism of heredity. The fundamental principle of organic evolution is improvement or retrogression through the selection of inherited anatomical features and physiological functions.
Our entire system of education is upside down because it studies only human behavior and not the human organism; we know virtually nothing at all of the most vital factor in human evolution-human heredity. I ask whether medical science is prepared to accept the responsibility for the reckless deterioration of human stock which it promotes by lavishing its skill and care upon the preservation of the unfit, when it takes no measures whatsoever for beginning the study of human inheritance by which alone permanent improvement of the species can be anticipated. I call upon this profession which is actually directing the course of human evolution downward to reflect upon the wages of biological sin.-EARNEST A. HOOTON. Twilight of Man. New York, G. P. Putnam, 1939, p. 
